Key result
Tricuspid valve repair was successfully performed in a 66-year-old man with pacemaker lead endocarditis caused by Staphylococcus hominis, with the patient remaining well at 3 years.
Why the study?
Does tricuspid valve repair improve outcomes in a patient with pacemaker lead endocarditis?
Case Report (n=1)
Does tricuspid valve repair improve outcomes in a patient with pacemaker lead endocarditis?
Answers are grounded in this paper and cite their sources.
Tricuspid valve repair can be a successful and durable surgical strategy for pacemaker lead endocarditis, avoiding the risks associated with prosthetic valve replacement.
In non-addicted patients, several states, such as permanent pacemakers, can provide the predisposing factors for tricuspid-valve endocarditis. In this report, we present a case of a 66-year-old man with pacemaker lead infection and tricuspid-native-valve endocarditis, related to Staphylococcus hominis, very rare cause of infective endocarditis that carries a high-mortality risk. Surgery was indicated for the patient due to persistent enlarging vegetation on the tricuspid valve, severe tricuspid regurgitation, septic pulmonary emboli and finally uncompensated respiratory and heart failure. Many ingenious methods have been devised to repair the tricuspid valve in patients with infective endocarditis. Valve replacement, however, is hazardous due to the possibility of prosthetic infection, and we choose to repair the native valve. The patient has now been weel for 3 years.
No takes yet. Share an insight, caveat, or question.
Iezzi et al. (2010) conducted a case report in Pacemaker lead infection and tricuspid-native-valve endocarditis (n=1). Tricuspid valve repair was evaluated on Clinical outcome. Tricuspid valve repair was successfully performed in a 66-year-old man with pacemaker lead endocarditis caused by Staphylococcus hominis, with the patient remaining well at 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: